Stryke Review: Options Routing, AMMs, RFQ & Execution Risk

Stryke, formerly Dopex, positions itself as options infrastructure rather than one standalone exchange. It describes routing across concentrated-liquidity AMMs, order books, and RFQ providers, including a stated Paradigm RFQ integration.

The decision is not only “should I trade here?” It is also “which venues and liquidity does this routing actually reach?”

What Stryke actually is

Stryke grew out of Dopex, an earlier Arbitrum options AMM. Its newer positioning focuses on routing orders to different execution paths.

The paths may include its own AMM, an order book, or an RFQ counterparty. Public discussion also references a sykAsh rebate mechanism. Verify its current rules in Stryke’s documentation.

Why “infra, not venue” matters for how you evaluate it

Stryke’s value depends on real routed orders and usable integrations. A standalone TVL or OI number would not prove that the routing works well.

Current routed volume was not independently verified here.

What Stryke does well—and what remains uncertain

• Pro: a genuinely different value proposition from a single-venue book — if the routing works as pitched, it could reduce fragmented liquidity across venue types rather than adding another isolated pool.
• Pro: builds on a multi-year Dopex lineage rather than starting from zero, with real operating history on Arbitrum specifically.
• Con: harder to evaluate than a standalone venue — its usefulness depends on integration depth and actual routed volume, neither of which we could independently verify here.
• Con: expansion plans (additional chains, additional integrations) are, as of this writing, plans rather than confirmed live deployments — check current status directly.
• Con: Stryke’s current audit status and live fee/rebate schedule remain unresolved — confirm both before relying on it.

Who should choose Stryke

Traders and builders more interested in execution routing and infra-level integration than in picking a single venue to trade on directly, and anyone evaluating whether Paradigm RFQ liquidity is reachable through multiple onchain paths, not just Paradex.

Risks specific to Stryke

Beyond normal options risk, Stryke depends on the venues it routes into. Thin liquidity or a changed rebate program can reduce the benefit of the routing layer.

Confirm which execution paths are live and liquid today. A listed integration is not proof of usable liquidity.

What to verify before using Stryke

Stryke’s documented identity is an execution-routing layer with Dopex lineage; the uncertain part is how much live flow it routes and through which integrations. Verify current chain support, active execution paths, rebate conditions, and audit coverage in Stryke’s own documentation before treating a routing relationship or RFQ reference as evidence of usable liquidity.